HealthEquity Q2 revenue up 23% to $299.9M; EPS $0.40; raises guidance, $300M buyback

HEALTHEQUITY, INC.

2025-Q2 EPS reported $0.73 revenue$587,525,000

Revenue $299.9M, +23% YoY; net income $35.8M ($0.40 diluted EPS) vs $10.6M ($0.12) last year.
Non-GAAP net income $76.3M ($0.86 diluted) vs $45.6M ($0.53); Adj. EBITDA $128.3M (43% margin) vs $88.1M (36%).
HSA accounts 9.4M (+15% YoY); total HSA Assets $29.5B (+27%).
New $300M stock repurchase program authorized by Board.
Guidance raised: FY2025 revenue $1.165B-$1.185B; Adj. EBITDA $458M-$478M.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.